Sabiha Moonmoon
Sabiha Moonmoon has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Francois Brochet
Boston University
1 shared publication
Latest Publications
- Open Access
- 11 November 2026
- Published by Elsevier in SSRN Electronic Journal
When Quarterly Reporting Becomes Optional: The Role of Prior Disclosure Practices
We examine how investors' reactions to proposed flexibility in mandatory reporting frequency vary with firms' pre-existing voluntary disclosure practices. Using three U.S. policy events during 2025-2026, we compare firms with established quarterly management guidance practices with firms that provide guidance only at an annual horizon. Annual-only guiders experience announcement returns approximately 100 basis points lower than quarterly guiders. The difference is negative around each event, persists across alternative definitions and measurement windows for quarterly guidance, and is unusually large relative to return differentials observed on placebo dates. Because the proposed regime has not yet been implemented, these reactions reflect investors' expectations about firms' reporting choices and their consequences. Overall, our findings suggest that investors' assessments of reporting-frequency flexibility depend on firms' established voluntary disclosure practices.
- 11 November 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessWhen Quarterly Reporting Becomes Optional: The Role of Prior Disclosure Practices
We examine how investors' reactions to proposed flexibility in mandatory reporting frequency vary with firms' pre-existing voluntary disclosure practices. Using three U.S. policy events during 2025-2026, we compare firms with established quarterly management guidance practices with firms that provide guidance only at an annual horizon. Annual-only guiders experience announcement returns approximately 100 basis points lower than quarterly guiders. The difference is negative around each event, persists across alternative definitions and measurement windows for quarterly guidance, and is unusually large relative to return differentials observed on placebo dates. Because the proposed regime has not yet been implemented, these reactions reflect investors' expectations about firms' reporting choices and their consequences. Overall, our findings suggest that investors' assessments of reporting-frequency flexibility depend on firms' established voluntary disclosure practices.